75% of blood coming to the liver arrives directly from gastrointestinal organs and the spleen via portal veins that bring drugs and xenobiotics in near-undiluted form. Several mechanisms are responsible for either inducing hepatic injury or worsening the damage process. Many chemicals damage  mitochondria, an intracellular organelle that produces energy. Its dysfunction releases excessive amount of oxidants that, in turn, injure hepatic cells. Activation of some enzymes in the cytochrome P-450 system such as  CYP2E1 also lead to oxidative stress. Injury to hepatocyte and bile duct cells lead to accumulation of bile acid inside the liver. This promotes further liver damage. Non-parenchymal cells such as Kupffer cells, collagen-producing stellate cells, and leukocytes (i.e. neutrophil and monocyte) also have a role in the mechanism. Drug metabolism in liver
The human body subjects most, but not all, compounds to various chemical processes (i.e. metabolism) to make them suitable for elimination. This involves chemical transformations to (a) reduce fat solubility and (b) to change biological activity. Although almost all tissues in the body have some ability to metabolize chemicals, smooth endoplasmic reticulum in the liver is the principal "metabolic clearing house" for both endogenous chemicals (e.g., cholesterol, steroid hormones,  fatty acids, proteins) and exogenous substances (e.g., drugs, alcohol). The central role played by liver in the clearance and transformation of chemicals makes it susceptible to drug-induced injury. Drug metabolism is usually divided into two phases: phase 1 and phase 2. Phase 1 reaction is generally speaking to prepare a drug for phase 2.
stem extracts
Siddiqui H (1993) Safety of herbal drugs-an overview. Drugs News Views
Kumar A, Rohal A, Chakraborty S, Tiwari R, Latheef SK, et al. (2013) Ocimum sanctum (Tulsi): a miracle herb and boon to medical science Review. Int J Agron Plant Prod 4: 589
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, et al. (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1
Singh N, Verma P, Pandey BR, Bhalla M (2012) Therapeutic potential of Ocimum sanctum in prevention and treatment of cancer and exposure to radiation: An overview. Int J Pharmacist Sci Drug Res 4: 97–104. Mondal S, Mirdha BR, Mahapatra SC (2009) The science behind sacredness of Tulsi (Ocimum sanctum Linn.). Indian J Physiol Pharmacol 53: 291–306. Devra D, Mathur KC, Agrawal RP, Bhadu I, Goyal S, et al. (2012) Effect of Tulsi (Ocimum sanctum Linn.) on Clinical and Biochemical Parameters of Metabolic Syndrome. J Nat Remedies 12: 63-67
Ahmad I, Beg AZ (2001) Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. Ethnopharmacol 74: 113–123. Amadi J, Salami S, Eze C (2010) Antifungal properties and phytochemical screening of extracts of African basil (Ocimum gratissimum L.). Agr Biol J North America 1: 163–166. Ponnusam Y, Louis T, Madhavachandran V, Kumar S, Thoprani N, et al. (2015) Antioxidant Activity of The Ancient Herb, Holy Basil in CCl4-Induced Liver Injury in Rats. Ayurvedic 2: 34–38. Ravi V, Parida S, Desai A, Chandramukhi A, Devi MG, et al.